Skip to main content
Log in

Cisplatin-induced gastric paresis

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Summary

A 27 year old male with metastatic testicular carcinoma was treated with cisplatin, vinblastine, and bleomycin (PVB) chemotherapy. After receiving a cumulative dose of 500 mg/m2 of cisplatin, he developed severe nausea and vomiting and had clinical evidence of a cisplatin-induced peripheral neuropathy. His vomiting resolved five weeks after discontinuation of cisplatin. We believe this case represents the first report of gastric autonomic neuropathy induced by cisplatin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Chabner B: Platinum complexes. In: Pharmacologic Principles of Cancer Treatment. WB Saunders, Philadelphia, 1982, pp 309–321

    Google Scholar 

  2. Einhorn LH, Donohue J: Cis-diaminedichloroplatinum vinblastine and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 87:293–298, 1977

    Google Scholar 

  3. Einhorn LH, Williams SD: Chemotherapy of disseminated testicular cancer. A random prospective study. Cancer 46:1339–1344, 1980

    Google Scholar 

  4. Taylor MH, Depetrillo AD, Turner AR: Vinbastine, bleomycin and cisplatin in malignant germ cell tumors of the ovary. Cancer 56(6):1341–1349, 1985

    Google Scholar 

  5. Rozenczweig M, Von Hoss DD, Slavik M, Muggia FM: Cisdiamminedichloroplatinum (II): A new anticancer drug. Ann Intern Med 86:803–812, 1977

    Google Scholar 

  6. Schilsky RL, Anderson T: Hypomagnesemia and renal magnesium wasting in patients receiving cisplatin. Ann Intern Med 90:929–931, 1979

    Google Scholar 

  7. Blachley JD, Hill JB: Renal and electrolyte disturbances associated with cisplatin. Ann Intern Med 95:628–632, 1981

    Google Scholar 

  8. Yagoda A, Watson RC, Kemeny N, Grabstald H, Whitmore Jr WF: Diamminedichloride platinum II and cyclophosphamide in the treatment of advanced urothelial cancer. Cancer 41:2121–2130, 1978

    Google Scholar 

  9. Einhorn LH, Furnas BE, Powell N: Combination chemotherapy of disseminated testicular carcinoma with cisplatinum, vinblastine and bleomycin (Abstr). Proc Amer Assoc Cancer Res/Proc Amer Soc Clin Oncol 17:249, C-13, 1976

    Google Scholar 

  10. Von Hoff DD, Schilsky R, Reichert CM, Reddick RL, Rozenczweig M, Young RC, Muggia FM: Toxic effects of cisdichlorodiammineplatinum (11) in man. Cancer Treat Rep 63:1527–1531, 1979

    Google Scholar 

  11. Ostrow S, Hahn D, Wiernik PH, Richards RD: Ophthalmologic toxicity after cis-dichlorodiammineplatinum (II) therapy. Cancer Treat Rep 62:1591–1594, 1978

    Google Scholar 

  12. Walsh TJ, Clark AW, Parhad IM, Green WR: Neurotoxic effects of cisplatin therapy. Arch Neurol 39:719–720, 1982

    Google Scholar 

  13. Berman IJ, Mann MP: Seizures and transient cortical blindness associated with cis-platinum (II) diamminedichloride (PDD) therapy in a thirty-year old man. Cancer 45:764–766, 1980

    Google Scholar 

  14. Mead GM, Arnold AM, Green JA, Macbeth FR, Williams CJ, Whitehouse JM: Epileptic seizures associated with cisplatin administration. Cancer Treat Rep 66:1719–1722, 1982

    Google Scholar 

  15. Kedar A, Cohen ME, Freeman AI: Peripheral neuropathy as a complication of cis-dichlorodiammineplatinum (II) treatment: a case report. Cancer Treat Rep 62:819–821, 1978

    Google Scholar 

  16. Ashraf M, Scotchel PL, Krall JM, Flink EB: Cis-platinum induced hypomagnesemia and peripheral neuropathy. Gyn Oncology 16:309–318, 1983

    Google Scholar 

  17. Thompson SW, Davis LE, Kornfeld M, Hilgers RD, Standefer JD: Cisplatin neuropathy: clinical, electrophysiologic, morphologic and toxologic studies. Cancer 54:1269–1275, 1984

    Google Scholar 

  18. Roelofs RI, Hrushnesky W, Rogin J, Rosenberg L: Peripheral sensory neuropathy and cisplatin chemotherapy. Neurology 34:934–938, 1984

    Google Scholar 

  19. Mollman JE, Glover DJ, Hogan WM, Freman RE: Cis-platin neuropathy: risk factors and a possible protective agent (Abstr). Neurology 35 (Suppl. 1):80, 1985

    Google Scholar 

  20. Rosenfeld CS, Broder LE: Cisplatin-induced autonomic neuropathy. Cancer Treat Rep 68:659–660, 1984

    Google Scholar 

  21. Kroop SH, Long W, Alavi A, Hansell JR: Effect of water and fat on gastric emptying of solid meals. Gastroent 77:997–999, 1979

    Google Scholar 

  22. Bradley WG, Lassman LP, Pearce GW, Walton JN: The neuromyopathy of vincristine in man. Clinical, electrophysiological and pathological studies. J Neurol Sci 10:107–131, 1970

    Google Scholar 

  23. Aisner J, Weiss HD, Chang P, Wiernik PH: Orthostatic hypotension during combination chemotherapy with vincristine (NSC-67574). Cancer Chemother Rep 58:927–930, 1974

    Google Scholar 

  24. Roca E, Bruera E, Politi PM, Barugel M, Cedaro L, Carraro S, Chacon RD: Vinca alkaloid-induced cardiovascular autonomic neuropathy. Cancer Treat Rep 69:149–151, 1985

    Google Scholar 

  25. Albibi R, McCallum RW: Metoclopramide: Pharmacology and clinical application. Ann Intern Med 98:86–95, 1983

    Google Scholar 

  26. Baldessarini RJ: Drugs and the treatment of psychiatric disorders. In: Goodman and Gillman's The Pharmacological Basis of Therapeutics. Gillman AG, Goodman LS, Gillman A (eds) Macmillan Publishing Co., New York, 1980, pp 403

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cohen, S.C., Mollman, J.E. Cisplatin-induced gastric paresis. J Neuro-Oncol 5, 237–240 (1987). https://doi.org/10.1007/BF00151227

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00151227

Key words

Navigation